Metraipolis › archive › dc_00c456b601fe

Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from… — Europe PMC PMID:41561108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41561108
DOI
10.1183/23120541.00565-2025
License (as archived)
solo-consultazione
Archived
2026-11-06T17:19:59.461Z
SHA-256 of the archived text
80a67d2ffd6c762466051155b373262b9f5a4bc3c47ba234486700689a43f5ce
Stable URL of this page
https://metraipolis.com/documento/dc_00c456b601fe

How to cite

Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from… — Europe PMC PMID:41561108 — Europe PMC (en), https://europepmc.org/article/MED/41561108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00c456b601fe (Metraipolis archive dc_00c456b601fe, sha256 80a67d2ffd6c762466051155b373262b9f5a4bc3c47ba234486700689a43f5ce)
BibTeX
@misc{dc00c456b601fe,
  title = {Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from… — Europe PMC PMID:41561108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41561108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00c456b601fe; sha256 80a67d2ffd6c762466051155b373262b9f5a4bc3c47ba234486700689a43f5ce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41561108. Agents can read the archived copy with the MCP tool read_document.